论文信息 - Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists - 字舞流文

Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists

M. Motaghinejad | M. Salehirad | M. Allahverdi Khani | S. Darbeheshti

[1] Lin Chen,et al. Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity , 2016, Nature Communications.

[2] R. Lukaszewski,et al. Targeting the “Cytokine Storm” for Therapeutic Benefit , 2013, Clinical and Vaccine Immunology.

[3] J. G. van der Hoeven,et al. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. , 2009, Biochemical pharmacology.

[4] L. Ulloa,et al. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation , 2007, British journal of pharmacology.

[5] L. Ulloa,et al. High-mobility group box 1 (HMGB1) protein: friend and foe. , 2006, Cytokine & growth factor reviews.